Suppr超能文献

乳腺印戒细胞样弥漫大 B 细胞淋巴瘤 1 例报告。

Signet ring cell-like diffuse large B-cell lymphoma involving the breast: a case report.

机构信息

Department of Pathology, Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China.

出版信息

BMC Womens Health. 2023 Mar 23;23(1):119. doi: 10.1186/s12905-023-02285-4.

Abstract

BACKGROUND

Diffuse large B-cell lymphoma (DLBCL) with signet ring cell components is extremely rare. Here, we present a case of DLBCL with signet ring cell components involving the breast, which can be easily confused with invasive lobular carcinoma of the breast or metastatic signet ring cell carcinoma of gastrointestinal origin.

CASE PRESENTATION

A 66-year-old woman presented with a painless mass in her left breast. Enhanced magnetic resonance imaging (MRI) of the breast revealed a 42 × 29 × 28 mm mass in the left breast. Histological examination revealed a diffuse or scattered arrangement of round cells mixed with signet ring-like cells. Immunohistochemically, the neoplastic cells were positive for PAX-5, CD79a, CD20, Bcl-6, and MUM-1 but and negative for cytokeratin, ER, PR, E-cadherin, and P120. The Ki-67 proliferation index was approximately 70%. Fluorescence in situ hybridisation (FISH) demonstrated non-rearrangement of Bcl-2, Bcl-6, and c-MYC genes. Immunohistochemistry and FISH examination confirmed the diagnosis of DLBCL. Subsequently, immunofluorescence showed both IgM and IgG deposits in the signet ring-like lymphocytes. After confirming the diagnosis, the patient received four courses of CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone) chemotherapy in a specialist hospital and achieved partial remission; however, she unfortunately died of secondary pneumocystis pneumonia infection 3 months later.

CONCLUSION

Malignant lymphoma with signet ring cell morphology is quite uncommon, and this variant can be a diagnostic pitfall. We emphasise that pathologists should consider lymphoma in the differential diagnosis of malignant breast tumours.

摘要

背景

具有印戒细胞成分的弥漫性大 B 细胞淋巴瘤(DLBCL)极为罕见。在这里,我们报告了一例涉及乳房的具有印戒细胞成分的 DLBCL,它很容易与乳腺浸润性小叶癌或源自胃肠道的转移性印戒细胞癌相混淆。

病例介绍

一名 66 岁女性因左乳无痛性肿块就诊。乳腺增强磁共振成像(MRI)显示左乳有一个 42×29×28 毫米的肿块。组织学检查显示圆形细胞弥漫性或散在排列,混合有印戒样细胞。免疫组化显示,肿瘤细胞阳性表达 PAX-5、CD79a、CD20、Bcl-6 和 MUM-1,但阴性表达细胞角蛋白、ER、PR、E-钙黏蛋白和 P120。Ki-67 增殖指数约为 70%。荧光原位杂交(FISH)显示 Bcl-2、Bcl-6 和 c-MYC 基因无重排。免疫组化和 FISH 检查证实了 DLBCL 的诊断。随后,免疫荧光显示印戒样淋巴细胞中既有 IgM 又有 IgG 沉积。在确诊后,患者在一家专科医院接受了四个疗程的 CHOP(环磷酰胺、多柔比星、长春新碱和泼尼松)化疗,达到部分缓解;然而,她不幸在 3 个月后因继发性肺孢子菌肺炎感染而死亡。

结论

具有印戒细胞形态的恶性淋巴瘤非常罕见,这种变异可能是诊断上的陷阱。我们强调,病理学家在鉴别诊断恶性乳腺肿瘤时应考虑淋巴瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8102/10035239/e80c891db2b1/12905_2023_2285_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验